Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

OrganOx Metra® New Enrollment PAS

ClinicalTrials.gov ID: NCT05526326

Public ClinicalTrials.gov record NCT05526326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OrganOx Metra® New Enrollment Post-Approval Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the OrganOx metra® New Enrollment Post-Approval Study is to collect data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on the OrganOx according to the current indications for use in the real-world setting.

Study identification

NCT ID
NCT05526326
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
OrganOx Ltd.
Industry
Enrollment
315 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2022 (Actual)
Primary completion
Feb 5, 2025 (Actual)
Completion
Feb 5, 2025 (Actual)
Last update posted
Apr 3, 2025

2022 – 2025

United States locations

U.S. sites
10
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Tampa General Hospital Tampa Florida 33606 —
Loyola University Maywood Illinois 60153 —
University of Michigan Ann Arbor Michigan 48109 —
Washington University St Louis Missouri 63110 —
Mount Sinai New York New York 10029 —
Duke University Durham North Carolina 27710 —
The Ohio State University Columbus Ohio 43210 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05526326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05526326 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →